Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Axsome Therapeutics stock in Canada | $65.32
Own Axsome Therapeutics shares in just a few minutes.
Axsome Therapeutics (AXSM) is a leading biotechnology business based in the US. It opened the day at $65.1 after a previous close of $64.81. During the day the price has varied from a low of $64.21 to a high of $66.12. The latest price was $65.32 (25 minute delay). Axsome Therapeutics is listed on the NASDAQ and employs 70 staff. All prices are listed in US Dollars.
How to buy Axsome Therapeutics stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: AXSM in this case.
- Research Axsome Therapeutics stocks. The platform should provide the latest information available.
- Buy your Axsome Therapeutics stocks. It's that simple.
What's in this guide?
- Can I buy shares in Axsome Therapeutics?
- Has coronavirus impacted Axsome Therapeutics shares?
- Axsome Therapeutics shares summary
- Compare share dealing platforms
- Is Axsome Therapeutics stock a buy or sell?
- Axsome Therapeutics performance over time
- Can I short Axsome Therapeutics shares?
- Axsome Therapeutics's financials
- How volatile are Axsome Therapeutics shares?
- Does Axsome Therapeutics pay a dividend?
- Other common questions
How has Coronavirus impacted Axsome Therapeutics's stock price?
Since the stock market crash in March caused by coronavirus, Axsome Therapeutics's stock price has had significant negative movement.
Its last market close was $60.71, which is 33.38% down on its pre-crash value of $91.13 and 71.30% up on the lowest point reached during the March crash when the stocks fell as low as $35.44.
If you had bought $1,000 worth of Axsome Therapeutics stocks at the start of February 2020, those stocks would have been worth $680.64 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $646.56.
Axsome Therapeutics stock priceUse our graph to track the performance of AXSM stocks over time.
Axsome Therapeutics stocks at a glance
|52-week range||$50.05 - $87.24|
|50-day moving average||$63.1177|
|200-day moving average||$63.7143|
|Wall St. target price||$140.21|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.374|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Axsome Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Axsome Therapeutics price performance over time
|1 month (2021-07-02)||-1.09%|
|3 months (2021-05-04)||12.47%|
Axsome Therapeutics financials
|Gross profit TTM||USD$0|
|Return on assets TTM||-32.37%|
|Return on equity TTM||-78.97%|
|Market capitalisation||USD$1.9 billion|
TTM: trailing 12 months
How to short and sell Axsome Therapeutics stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "AXSM.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 2.7 million Axsome Therapeutics stocks held short by investors – that's known as Axsome Therapeutics's "short interest". This figure is 6.3% down from 2.9 million last month.
There are a few different ways that this level of interest in shorting Axsome Therapeutics stocks can be evaluated.
Axsome Therapeutics's "short interest ratio" (SIR)
Axsome Therapeutics's "short interest ratio" (SIR) is the quantity of Axsome Therapeutics stocks currently shorted divided by the average quantity of Axsome Therapeutics stocks traded daily (recently around 368660.65128901). Axsome Therapeutics's SIR currently stands at 7.37. In other words for every 100,000 Axsome Therapeutics stocks traded daily on the market, roughly 7370 stocks are currently held short.
However Axsome Therapeutics's short interest can also be evaluated against the total number of Axsome Therapeutics stocks, or, against the total number of tradable Axsome Therapeutics stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Axsome Therapeutics's short interest could be expressed as 0.07% of the outstanding stocks (for every 100,000 Axsome Therapeutics stocks in existence, roughly 70 stocks are currently held short) or 0.092% of the tradable stocks (for every 100,000 tradable Axsome Therapeutics stocks, roughly 92 stocks are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the stock price, with fewer people currently willing to bet against Axsome Therapeutics.
Find out more about how you can short Axsome Therapeutics stock.
Axsome Therapeutics stock dividends
We're not expecting Axsome Therapeutics to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Axsome Therapeutics stock price volatility
Over the last 12 months, Axsome Therapeutics's stocks have ranged in value from as little as $50.05 up to $87.24. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Axsome Therapeutics's is 2.525. This would suggest that Axsome Therapeutics's stocks are significantly more volatile than the average for this exchange and represent a higher risk.
Axsome Therapeutics overview
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05 for the treatment major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial for the treatment of Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. The company is also developing AXS-07 for the treatment of migraine; AXS-12 for the treatment of narcolepsy; and AXS-14 for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.
Stocks similar to Axsome Therapeutics
Axsome Therapeutics in the news
3 “Strong Buy” Stocks Trading at Steep Discounts
Is There Any Hope Left for Axsome Therapeutics?
Stocks That Hit 52-Week Lows On Friday
Frequently asked questions
More guides on Finder
How to buy Wheels Up (UP) stock in Canada when it goes public
Everything we know about the Wheels Up IPO, plus information on how to buy in.
How to buy Brookfield Asset Management Reinsurance Partners Ltd (BAMR) stock in Canada when it goes public
Everything we know about the Brookfield Asset Management Reinsurance Partners Ltd IPO, plus information on how to buy in.
How to buy Traeger (COOK) stock in Canada
Everything we know about the Traeger IPO, plus information on how to buy in.
How to buy Teads (TEAD) stock in Canada when it goes public
Everything we know about the Teads IPO, plus information on how to buy in.
How to buy Snap One Holdings Corp (SNPO) stock in Canada
Everything we know about the Snap One Holdings Corp IPO, plus information on how to buy in.
How to buy Riskified (RSKD) stock in Canada
Everything we know about the Riskified IPO, plus information on how to buy in.
How to buy Preston Hollow Community Capital (PHCC) stock in Canada when it goes public
Everything we know about the Preston Hollow Community Capital IPO, plus information on how to buy in.
How to buy PowerSchool Holdings (PWSC) stock in Canada
Everything we know about the PowerSchool Holdings IPO, plus information on how to buy in.
How to buy MeridianLink (MLNK) stock in Canada
Everything we know about the MeridianLink IPO, plus information on how to buy in.
How to buy Dole (DOLE) stock in Canada
Everything we know about the Dole IPO, plus information on how to buy in.
Ask an Expert
You must be logged in to post a comment.